Compare Mitra Komunikasi Nusantara Tbk. (MKNT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Komunikasi Nusantara Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra Komunikasi Nusantara Tbk. trades at Rp1 (market cap 5.5B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 19× Mitra Komunikasi Nusantara Tbk.'s market cap. Which is the better fit depends on your goals.
| MKNT | SCPI | |
|---|---|---|
Market Cap | 5.5B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Komunikasi Nusantara Tbk.
PT Mitra Komunikasi Nusantara Tbk (the Company) was founded in July 14, 2008 as a company engaged in general trade mainly Cellular phone (Mobile), gadgets (smartphone, tablet, etc.) and refill voucher.The Company is the sole agent Electronic devices (Gadgets) by Cyrus brand, as well as Importer and Wholesaler for products Cyrus. The Company cooperated with Telecommunications Operators in Indonesia in distributing Voucher Recharge with Mobile Products Company, and sold in Wholesale or Ritail directly to the user. including PT Telkomsel Indonesia Tbk, PT Indosat Tbk, PT XL Axiata Tbk, PT Telkom Indonesia Tbk, PT Hutchison 3 Indonesia.
Read more on MKNT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
